里氏木霉细胞表面表达系统的构建

[目的]烟曲霉(Aspergillus fumigatus)的AfMp1p是一种通过糖基磷脂酰肌醇( glycosylphosphatidylinositol,GPI)修饰定位于细胞壁上的蛋白,其细胞壁定位信号位于蛋白质的C末端.里氏木霉(Trichoderma reesei)是一种重要的工业生产菌种.构建里氏木霉的细胞表面表达系统具有十分重要的意义.[方法]我们将AfMp1p的细胞壁定位GPI信号肽和烟曲霉几丁质酶AfChiB1的N端信号肽分别与绿色荧光蛋白(green fluorescent protein,GFP)的C末端和N末端融合并转化里氏木霉.本文首先对木霉遗传转化系统进行了优化;随后通过Real-time PCR和蛋白定量,对GFP融合蛋白在里氏木霉中不同时期的表达情况进行了研究;最后对里氏木霉表达的GFP融合蛋白进行细胞定位研究.[结果]荧光观察结合Western blot的结果表明,在平台期中期和后期,带有GPI信号的GFP融合蛋白定位于细胞壁.[结论]烟曲霉来源的GPI信号可被里氏木霉识别,本论文所构建的表达系统可用于外源蛋白在里氏木霉中的细胞壁定位表达.     

高浓度氯苯优势降解菌的筛选及其降解酶的纯化

[目的]分离纯化出一株高浓度氯苯优势降解菌株,对其所产氯苯降解酶进行分离与纯化,为该菌株及其氯苯降解酶的研究提供理论参考.[方法]利用梯度富集培养技术和无菌滤纸片平板法分离菌株,通过形态特征及16S rRNA基因序列分析初步鉴定菌株,用气相色谱法测定培养液中氯苯浓度,以单位细胞氯苯降解率评价菌株对氯苯的降解能力,以氯苯降解率表示氯苯降解酶的活性.取纯化菌株的发酵酶液制备粗酶液,经硫酸铵梯度盐析、透析脱盐、DE-52离子交换层析、G-100凝胶层析和透析浓缩后,进行SDS-PAGE凝胶电泳检验酶的纯度并测定酶的分子量.[结果]从氯苯长期驯化的成熟期活性污泥中筛选到一株以氯苯为唯一碳源和能源的氯苯优势降解细菌LW13,该菌株在以2000 mg/L氯苯为唯一碳源的无机盐培养基中仍能正常生长,其单位细胞氯苯降解率可达1.37 ×10-10.扫描电镜观察到该菌株细胞大小约为2.3 ×0.8μm,长有数根端生鞭毛.16S rRNA基因序列相似性比较表明该菌株与Lysinibacillus fusiformis(溶藻菌)的相似性达95.5％.所纯化的氯苯降解酶为胞外酶,带正电荷,其分子大小约为57 kDa.整个纯化过程中酶纯化倍数化达8.0倍,酶活回收率达52.51％,酶量回收率达6.57％.纯化后的氯苯降解酶在30℃-55℃和pH在6.0-8.0之间都保持较高的酶活性,其最适反应温度和pH分别在40℃和pH8.0左右.[结论]所分离的氯苯优势降解菌属于Lysinibacillus属菌株,该菌株能有效降解高浓度(500-2000 mg/L)氯苯废水,通过逐级分离纯化,可获得氯苯降解酶纯酶,纯化指标符合分离纯化基本规律,纯化效果较为理想.     

云南阳宗海酵母菌种群结构及产胞外酶测试北大核心CSCD

【目的】研究阳宗海酵母菌种群结构,分析生物因子及非生物因子对酵母菌种群分布的影响;测试阳宗海酵母菌产胞外酶活性。【方法】水样用醋酸纤维素滤膜过滤,原位培养分离酵母菌;梯度稀释法分离土样和底泥样品;对分离得到的菌株进行DNA提取和测序,分析26S rDNA的D1/D2区域,并结合形态及生理生化指标进行鉴定;用产酶筛选培养基对分离得到的酵母菌进行产胞外酶活性测试。【结果】共分离得到201株酵母菌,鉴定分属于15个属48个种,其中包括10个潜在的新种;普鲁兰类酵母(Aureobasidium pullulans),库德里阿兹威氏毕赤酵母(Pichia kudriavzevii),胶红酵母(Rhodotorula mucilaginosa),Cryptococcus podzolicus是优势种;15.9%的酵母菌具有产胞外酶活性,主要是脂肪酶和淀粉酶。【结论】阳宗海酵母菌有较为丰富的多样性,人为活动对阳宗海酵母菌分布影响较大,其次浊度、电导率也是影响酵母菌种群分布的重要因素;阳宗海产胞外酶酵母菌可能参与湖泊生态系统的自然循环。     

Vibrio zhuhaiensis sp. nov., isolated from a Japanese prawn (Marsupenaeus japonicus)

A Gram-negative, oxidase-positive, facultatively anaerobic bacterium, designated strain E20121, was isolated from the digestive tract of a Japanese prawn (Marsupenaeus japonicus) collected from the coastal sea water area of Zhuhai, Guangdong province, China. The new isolate was determined to be closely related to Vibrio ponticus DSM 16217^T, having 97.6 % 16S rRNA gene sequence similarity. Phylogenetic analysis based on recA, pyrH and rpoA also showed low levels of sequence similarities (72.6–96.6 %) with all species of the genus Vibrio. A multigene phylogenetic tree using concatenated sequences of the four genes (16S rRNA, rpoA, recA and pyrH) clearly showed that the new isolate is different from the currently known Vibrio species. DNA–DNA hybridization experiments revealed similarity values below 70 % with the closest related species V. ponticus DSM 16217^T. Several phenotypic traits enabled the differentiation of strain E20121 from the closest phylogenetic neighbours. The DNA G+C content of strain E20121 was determined to be 47.6 mol % and the major fatty acid components identified were C_16:1ω7c and/or C_16:1ω6c (39.8 %), C_18:1ω7c (13.6 %) and C_16:0 (9.6 %). Based on genotypic, phenotypic, chemotaxonomic, phylogenetic and DNA–DNA hybridization analyses, strain E20121 is proposed to represent a novel species of the genus Vibrio for which the name Vibrio zhuhaiensis sp. nov. is proposed. The type strain is E20121^T(=DSM 25602^T = CCTCC AB 2011174^T).     

A Recurrent PDGFRB Mutation Causes Familial Infantile Myofibromatosis

Infantile myofibromatosis (IM) is the most common benign fibrous tumor of soft tissues affecting young children. By using whole-exome sequencing, RNA sequencing, and targeted sequencing, we investigated germline and tumor DNA in individuals from four distinct families with the familial form of IM and in five simplex IM cases with no previous family history of this disease. We identified a germline mutation c.1681C>T (p.Arg561Cys) in platelet-derived growth factor receptor β (PDGFRB) in all 11 affected individuals with familial IM, although none of the five individuals with nonfamilial IM had mutations in this gene. We further identified a second heterozygous mutation in PDGFRB in two myofibromas from one of the affected familial cases, indicative of a potential second hit in this gene in the tumor. PDGFR-β promotes growth of mesenchymal cells, including blood vessels and smooth muscles, which are affected in IM. Our findings indicate p.Arg561Cys substitution in PDGFR-β as a cause of the dominant form of this disease. They provide a rationale for further investigations of this specific mutation and gene to assess the benefits of targeted therapies against PDGFR-β in aggressive life-threatening familial forms of the disease.     

C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells

The c-Myc oncogene is amplified in many tumor types. It is an important regulator of cell proliferation and has been linked to altered miRNA expression, suggesting that c-Myc-regulated miRNAs might contribute to tumor progression. Although miR-26a has been reported to be upregulated in glioblastoma multiforme (GBM), the mechanism has not been established. We have shown that ectopic expression of miR-26a influenced cell proliferation by targeting PTEN, a tumor suppressor gene that is inactivated in many common malignancies, including GBM. Our findings suggest that c-Myc modulates genes associated with oncogenesis in GBM through deregulation of miRNAs via the c-Myc–miR-26a–PTEN signaling pathway. This may be of clinical relevance.